mounjaro glp 1 gip (tirzepatide) is a dual incretin agonist targeting both GLP-1 and receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Tirzepatide (Mounjaro)

It is normally conjugated by glutathione (GSH), but when taken in excess, the body's glutathione reserves are not sufficient to deactivate the toxic NAPQI

In each step, unconventional reaction conditions are imposed, such as carbonyl dimethylacetone (DCC) and N,N-dimethylamine (DMAP), and strong acids such as trifluoroacetic acid are used to remove the protecting groups

B12 supplements are available in various forms, including cyanocobalamin (the most stable and commonly used form) and methylcobalamin (a naturally occurring form)

These medications require a healthcare providers prescription and monitoring to ensure they are used effectively and safely